This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here. When the covid pandemic hit, our antiviral coffers were essentially bare. Sure, pharmaceutical companies had developed drugs to combat influenza and a handful of chronic infections.……
Read More
How open-source drug discovery could help us in the next pandemic
Previous ArticleHere’s What Tokens Were Stolen In The $125 Million Poloniex Hack